Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
26 studies found for:    Progressive Multifocal Leukoencephalopathy
Show Display Options
Rank Status Study
21 Recruiting Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Condition: Kidney Transplantation
Intervention: Drug: No Intervention
22 Completed JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab
Condition: Relapsing Multiple Sclerosis
Intervention: Drug: natalizumab
23 Terminated
Has Results
Long-term Efficacy and Safety of Repeated Ofatumumab Treatment Courses in RA Patients Who Previously Received Ofatumumab or Placebo in Trial Hx-CD20-403
Condition: Arthritis, Rheumatoid
Intervention: Drug: ofatumumab
24 Completed Pharmacokinetic, Immunological and Biochemical Sample Collection and Analysis of a Tysabri Patient Cohort
Conditions: Multiple Sclerosis;   Relapse
Intervention:
25 Completed Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in Natalizumab Population With Active Control
Condition: Multiple Sclerosis
Intervention:
26 Unknown  Drug Exposure Registry for GSK2248761, an Investigational NNRTI
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK2248761

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-26) Next Page   
Indicates status has not been verified in more than two years